Viatris to buy pain therapy maker Pacira Biosciences for $1.65 billion

Viatris said on Thursday ‌it will buy Pacira Biosciences for $1.65 billion, adding the ​pain therapy maker's ​products to its portfolio.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。